Raxibacumab (1 brand name, 1 dosage form, 1 route)
Available dosage forms: INJECTABLE.
Routes of administration: IV (INFUSION).
Brand Names
- RAXIBACUMAB
Boxed Warning
• Hypersensitivity reactions, including anaphylaxis, have been reported during or after the administration of raxibacumab by intravenous infusion [see Warnings and Precautions (5.1)]. • Administer raxibacumab by intravenous infusion in monitored settings where appropriate equipment, medication (including epinephrine) and personnel trained in the management of hypersensitivity, anaphylaxis, and shock are available [see Warnings and Precautions (2.3, 5.1)].
Contraindications
None.
Mechanism of Action
Raxibacumab is a monoclonal antibody that binds the protective antigen of B. anthracis [see Microbiology (12.4)].
Overdosage
There is no clinical experience with overdosage of raxibacumab. In case of overdosage, monitor patients for any signs or symptoms of adverse effects.